Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension

Heart Lung Circ. 2024 Jan;33(1):12-13. doi: 10.1016/j.hlc.2023.10.010. Epub 2023 Nov 30.

Authors

Giuditta Benincasa¹, Maria Grazia Strozziero², Ugo Trama³, Claudio Napoli⁴

Affiliations

¹ Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Naples, Italy. Electronic address: giuditta.benincasa@unicampania.it.
² IRCCS Synlab SDN, Naples, Italy.
³ Regional Pharmaceutical Unit, Campania Region, Naples, Italy.
⁴ Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Naples, Italy.

PMID: 38040502
DOI: 10.1016/j.hlc.2023.10.010

No abstract available

Keywords: Omics; Pulmonary arterial hypertension; Sotatercept.

Publication types

Editorial

MeSH terms

Familial Primary Pulmonary Hypertension
Humans
Pulmonary Arterial Hypertension* / drug therapy
Recombinant Fusion Proteins

Substances

ACE-011
Recombinant Fusion Proteins